Company intelligence / Profile preview
NovoBiotic Pharmaceuticals
Cambridge, MA, United Statesnovobiotic.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
NovoBiotic has discovered several new classes of antibiotics using its proprietary platform. Lead compounds such as teixobactin and clovibactin have demonstrated potent activity against multidrug-resistant Gram-positive pathogens with no detectable resistance observed in preclinical models. The company is also exploring antifungal agents targeting urgent threats like Candida auris. All lead programs are currently at the preclinical stage.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecules (natural products/antibiotics)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborations with Northeastern University and international academic labs for compound discovery and validationNIH/NIAID grant support for antifungal drug discovery projects.
Beyond the preview
Go deeper on NovoBiotic Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NovoBiotic Pharmaceuticals.